Company intelligence / Profile preview

Sun Genomics

San Diego, California, USAflore.com ↗

Ownership: Private
Development stage: Commercial

Overview

Sun Genomics offers personalized probiotics based on individual gut microbiome analysis. Their products have shown positive results in addressing digestive issues, with some users reporting they were able to stop daily medication for intestinal issues and reintroduce previously problematic foods.

Therapeutic areas: Gastroenterology
Modalities: ProbioticsSynbioticsMultivitamins
Industry: Non-Drug Biotech

Drug pipeline

2 assets

Floré

Commercial

Indications: Gastrointestinal disorders

1 more asset in the full pipeline.

Request access →

Partnerships

Illuminadsm-firmenichArizona State University

Beyond the preview

Go deeper on Sun Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sun Genomics.

Explore the full profile